Welcome to our dedicated page for Cambridge Acquisition SEC filings (Ticker: CAQUU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cambridge Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cambridge Acquisition's regulatory disclosures and financial reporting.
Cambridge Acquisition Corp., a newly formed SPAC, completed its initial public offering of 23,000,000 units at $10.00 per unit, generating $230,000,000 in gross proceeds. Each unit includes one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50 per share.
The company simultaneously sold 495,500 private units to its sponsor at $10.00 per unit for $4,955,000. As of February 9, 2026, $230,000,000, including $8,050,000 in deferred underwriting commissions, was placed in a trust account for the benefit of public shareholders.
Cambridge Acquisition Corp. submitted a Form 3 identifying Bradley Christopher as a director of the company. The provided data does not list any share purchase, sale, or other insider transactions, and no share amounts are shown for this reporting person.
Cambridge Acquisition Corp. is offering 20,000,000 units at $10.00 per unit for an aggregate public offering of $200,000,000 (or $230,000,000 if the underwriters’ overallotment option is exercised in full). Each unit consists of one Class A ordinary share and one‑third of one redeemable warrant; whole warrants will be exercisable to purchase one Class A ordinary share at an exercise price of $11.50, subject to adjustment.
The prospectus states that $200,000,000 (or $230,000,000) of the offering proceeds will be held in a U.S. trust account pending an initial business combination, public shareholders will have redemption rights upon completion of a business combination, and sponsor founder shares and private placement units create potential dilution and conflict‑of‑interest considerations.